
Third Harmonic Bio, Inc. – NASDAQ:THRD
Third Harmonic Bio stock price today
Third Harmonic Bio stock price monthly change
Third Harmonic Bio stock price quarterly change
Third Harmonic Bio stock price yearly change
Third Harmonic Bio key metrics
Market Cap | 471.31M |
Enterprise value | N/A |
P/E | -1.66 |
EV/Sales | N/A |
EV/EBITDA | -8.06 |
Price/Sales | N/A |
Price/Book | 0.20 |
PEG ratio | N/A |
EPS | -0.37 |
Revenue | N/A |
EBITDA | -21.53M |
Income | -14.90M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeThird Harmonic Bio stock price history
Third Harmonic Bio stock forecast
Third Harmonic Bio financial statements
Jun 2023 | 0 | -7.56M | |
---|---|---|---|
Sep 2023 | 0 | 7.34M | |
Dec 2023 | 836K | -6.83M | -817.7% |
Mar 2024 | 0 | -7.85M |
Dec 2023 | 836K | -6.83M | -817.7% |
---|---|---|---|
Mar 2024 | 0 | -7.85M | |
Oct 2025 | 0 | -10.45M | |
Dec 2025 | 0 | -12.86M |
Analysts Price target
Financials & Ratios estimates
2023-11-09 | -0.39 | -0.19 |
---|---|---|
2024-03-26 | -0.33 | 0.17 |
2024-05-15 | -0.33 | -0.2 |
Jun 2023 | 285822000 | 7.81M | 2.73% |
---|---|---|---|
Sep 2023 | 282250000 | 9.29M | 3.29% |
Dec 2023 | 277711000 | 8.62M | 3.11% |
Mar 2024 | 270521000 | 7.02M | 2.59% |
Jun 2023 | -3.96M | -168K | 58K |
---|---|---|---|
Sep 2023 | -4.18M | 0 | -57K |
Dec 2023 | -5.60M | -1K | 798K |
Mar 2024 | -6.29M | 0 | 49K |
Third Harmonic Bio alternative data
Aug 2023 | 28 |
---|---|
Sep 2023 | 31 |
Oct 2023 | 31 |
Nov 2023 | 31 |
Dec 2023 | 32 |
Jan 2024 | 32 |
Feb 2024 | 32 |
Mar 2024 | 30 |
Apr 2024 | 30 |
May 2024 | 30 |
Jun 2024 | 31 |
Jul 2024 | 31 |
Third Harmonic Bio other data
Period | Buy | Sel |
---|---|---|
Dec 2023 | 0 | 17653 |
Apr 2024 | 0 | 14665 |
May 2024 | 0 | 44842 |
Jun 2024 | 0 | 10494 |
-
What's the price of Third Harmonic Bio stock today?
One share of Third Harmonic Bio stock can currently be purchased for approximately $5.38.
-
When is Third Harmonic Bio's next earnings date?
Unfortunately, Third Harmonic Bio's (THRD) next earnings date is currently unknown.
-
Does Third Harmonic Bio pay dividends?
No, Third Harmonic Bio does not pay dividends.
-
How much money does Third Harmonic Bio make?
Third Harmonic Bio has a market capitalization of 471.31M. Third Harmonic Bio made a loss 30.82M US dollars in net income (profit) last year or -$0.2 on an earnings per share basis.
-
What is Third Harmonic Bio's stock symbol?
Third Harmonic Bio, Inc. is traded on the NASDAQ under the ticker symbol "THRD".
-
What is Third Harmonic Bio's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Third Harmonic Bio?
Shares of Third Harmonic Bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Third Harmonic Bio have?
As Jul 2024, Third Harmonic Bio employs 31 workers, which is 3% more then previous quarter.
-
When Third Harmonic Bio went public?
Third Harmonic Bio, Inc. is publicly traded company for more then 2 years since IPO on 14 Sep 2022.
-
What is Third Harmonic Bio's official website?
The official website for Third Harmonic Bio is thirdharmonicbio.com.
-
Where are Third Harmonic Bio's headquarters?
Third Harmonic Bio is headquartered at 300 Technology Square, Cambridge, MA.
-
How can i contact Third Harmonic Bio?
Third Harmonic Bio's mailing address is 300 Technology Square, Cambridge, MA and company can be reached via phone at +61 79156680.
Third Harmonic Bio company profile:

Third Harmonic Bio, Inc.
thirdharmonicbio.comNASDAQ
51
Biotechnology
Healthcare
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Cambridge, MA 02139
CIK: 0001923840
ISIN: US88427A1079
CUSIP: 88427A107